Pharmaceutical Glass Ampoules Market Size

Pharmaceutical Glass Ampoules Market size was valued at USD 3.92 billion in 2023 and is expected to cross USD 9.56 billion by the end of 2036, registering more than 7.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of pharmaceutical glass ampoules is estimated at USD 4.14 billion.

The growth of the market can be attributed to the rapid growth of pharmaceutical industry around the globe, stringent government regulations to improve the quality of manufactured drugs, and the rising preference for injection based treatments, such as that of diabetes. Apart from these, the emergence of glass as a cost-effective, safe and efficient packaging solution is also expected to drive market growth in the near future. Furthermore, growing demand for COVID-19 vaccination across the world is evaluated to offer ample opportunities to the pharmaceutical glass ampoules market in 2021 and the following years. For instance, till date India has witnessed the largest demand for COVID-19 vaccines in the world. The country has secured more than 2 billion vaccine doses in total.

Frequently Asked Questions (FAQ)

Rapid growth of pharmaceutical industry and growing preference for injection based treatment globally are the major market growth drivers.

The market is anticipated to attain a significant CAGR over the forecast period, i.e., 2021 â€“ 2029.

Concerns regarding glass delamination while packaging drugs estimated to hamper the market growth.

Asia Pacific is expected to offer more growth opportunities to the market on the back of growing prevalence of chronic diseases and increasing disposable income.

The major players in the market are SCHOTT AG, PIRAMIDA d.o.o., Gerresheimer AG, NIPRO Corporation, Stevanato Group, and others.

Pharmaceutical Glass Ampoules Market Size